Simplex Trading
OMGA

Simplex Trading’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Simplex Trading’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,400
Closed -$2K – 9888
2024
Q3 		$2K Buy
2,400
+500
+26% +$796 ﹤0.01% 8110
2024
Q2 		$3K Sell
1,900
-1,300
-41% -$3.06K ﹤0.01% 8197
2024
Q1 		$11K Buy
3,200
+2,300
+256% +$8.82K ﹤0.01% 7574
2023
Q4 		$2K Buy
+900
New +$1.82K ﹤0.01% 8392
2023
Q3 		– Sell
-5,000
Closed -$28K – 10087
2023
Q2 		$28K Buy
5,000
+4,000
+400% +$31.3K ﹤0.01% 6438
2023
Q1 		$6K Sell
1,000
-3,900
-80% -$27.2K ﹤0.01% 7968
2022
Q4 		$27K Hold
4,900
– – ﹤0.01% 6590
2022
Q3 		$26K Sell
4,900
-24,700
-83% -$125K ﹤0.01% 7254
2022
Q2 		$112K Buy
29,600
+29,400
+14,700% +$109K ﹤0.01% 5428
2022
Q1 		$1K Buy
+200
New +$2.04K ﹤0.01% 10175

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Simplex Trading's OMGA Position: Q1 2025 in Review

Simplex Trading sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 342 shares.

Simplex Trading first reported a position in OMGA in Q1 2022 and held it in 10 quarters. The position peaked at $70K in Q3 2022. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Simplex Trading reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 342 Omega Therapeutics, Inc. Common Stock shares in Q1 2025.
  • Simplex Trading first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
  • Simplex Trading's Omega Therapeutics, Inc. Common Stock position peaked at $70K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.